CyrusOne Inc (NASDAQ:CONE) Shares Acquired by Zevin Asset Management LLC

Share on StockTwits

Zevin Asset Management LLC grew its position in CyrusOne Inc (NASDAQ:CONE) by 0.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 45,439 shares of the real estate investment trust’s stock after buying an additional 385 shares during the quarter. Zevin Asset Management LLC’s holdings in CyrusOne were worth $3,594,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in CONE. Opus Capital Group LLC purchased a new stake in shares of CyrusOne in the third quarter worth about $238,000. SG Americas Securities LLC increased its position in shares of CyrusOne by 25.8% during the 3rd quarter. SG Americas Securities LLC now owns 29,434 shares of the real estate investment trust’s stock valued at $2,328,000 after purchasing an additional 6,042 shares during the last quarter. First Trust Advisors LP grew its position in CyrusOne by 22.7% in the 3rd quarter. First Trust Advisors LP now owns 79,974 shares of the real estate investment trust’s stock valued at $6,326,000 after acquiring an additional 14,796 shares during the last quarter. Daiwa Securities Group Inc. grew its position in CyrusOne by 3.2% in the 3rd quarter. Daiwa Securities Group Inc. now owns 2,857,551 shares of the real estate investment trust’s stock valued at $226,032,000 after acquiring an additional 88,428 shares during the last quarter. Finally, Mackay Shields LLC bought a new position in CyrusOne in the 3rd quarter valued at $215,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

CONE stock traded down $0.47 during mid-day trading on Friday, hitting $65.60. The stock had a trading volume of 1,860,300 shares, compared to its average volume of 1,035,154. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 1.21. The firm has a fifty day simple moving average of $75.26 and a 200 day simple moving average of $65.83. The firm has a market capitalization of $7.82 billion, a P/E ratio of 19.82, a P/E/G ratio of 1.28 and a beta of 0.49. CyrusOne Inc has a 52 week low of $48.94 and a 52 week high of $79.73.

CyrusOne (NASDAQ:CONE) last posted its quarterly earnings data on Wednesday, October 30th. The real estate investment trust reported $0.14 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.89 by ($0.75). The company had revenue of $250.90 million during the quarter, compared to the consensus estimate of $247.81 million. CyrusOne had a negative return on equity of 0.08% and a negative net margin of 1.30%. The firm’s revenue for the quarter was up 21.4% on a year-over-year basis. During the same quarter last year, the company posted $0.79 earnings per share. As a group, equities analysts expect that CyrusOne Inc will post 3.57 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Investors of record on Thursday, January 2nd will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 3.05%. The ex-dividend date of this dividend is Tuesday, December 31st. CyrusOne’s dividend payout ratio (DPR) is 60.42%.

Several research firms have commented on CONE. Raymond James reaffirmed a “buy” rating and set a $82.00 price objective (up from $72.00) on shares of CyrusOne in a research note on Friday, November 1st. Morgan Stanley lifted their price objective on shares of CyrusOne from $68.00 to $78.50 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. Cowen lowered shares of CyrusOne from an “outperform” rating to a “market perform” rating in a research note on Friday, October 4th. ValuEngine lowered shares of CyrusOne from a “hold” rating to a “sell” rating in a research note on Friday. Finally, Zacks Investment Research lowered shares of CyrusOne from a “buy” rating to a “hold” rating in a research note on Tuesday, November 5th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and eleven have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $72.81.

In related news, CAO Mark Skomal sold 1,083 shares of the company’s stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $68.47, for a total value of $74,153.01. Following the transaction, the chief accounting officer now directly owns 5,515 shares in the company, valued at $377,612.05. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Kevin L. Timmons sold 24,000 shares of the company’s stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $70.53, for a total transaction of $1,692,720.00. Following the completion of the transaction, the executive vice president now owns 101,583 shares in the company, valued at $7,164,648.99. The disclosure for this sale can be found here. 1.40% of the stock is currently owned by corporate insiders.

CyrusOne Profile

CyrusOne (NASDAQ: CONE) is a high-growth real estate investment trust (REIT) specializing in highly reliable enterprise-class, carrier-neutral data center properties. The Company provides mission-critical data center facilities that protect and ensure the continued operation of IT infrastructure for approximately 1,000 customers, including 212 Fortune 1000 companies.

Featured Story: Percentage Gainers

Want to see what other hedge funds are holding CONE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CyrusOne Inc (NASDAQ:CONE).

Institutional Ownership by Quarter for CyrusOne (NASDAQ:CONE)

Receive News & Ratings for CyrusOne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CyrusOne and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.